+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Migraine Drugs Market 2024-2028 - Product Thumbnail Image

Migraine Drugs Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
From
From
From
RNA Targeting Small Molecule Drug Discovery Market Report 2026 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cancer Gene Therapy Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Cancer Gene Therapy Market - Forecasts from 2025 to 2030

  • Report
  • August 2025
  • 152 Pages
  • Global
From
Stroke Therapeutics Market 2021-2025 - Product Thumbnail Image

Stroke Therapeutics Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
Loading Indicator